Novo's Wegovy Secures Accelerated FDA Approval for MASH
Novo Nordisk's Wegovy (semaglutide) is now FDA-approved for metabolic dysfunction-associated steatohepatitis (MASH) with liver scarring, a significant advancement for this serious condition.
Feed↓
/ What's going on?
Filter:
Trump Admin Eyes Intel Equity Stake via Chips Act Funds
Trump administration considers using Chips Act funds for an equity stake in struggling Intel, signaling a new era of direct government intervention in US industrial policy for national security.
SharpLink's Ethereum Pivot & Q2 Loss
The sportsbook marketing company SharpLink Gaming shifts to an Ethereum treasury, acquiring 728,804 ETH. Q2 2025 results show a significant net loss driven by non-cash factors.
Nubank's Profit Surge: Deepening Customer Relationships
Nubank's Q2 profit hit $637M, revenue $3.7B, beating estimates. Delinquency 90-day: 6.6%. Shifts focus to deepening existing customer relationships for future growth in Brazil, adjusting credit models. Shares jumped
TeraWulf Secures $3.7B AI Colocation Deal with Fluidstack
TeraWulf secured a $3.7B AI deal with Fluidstack (Google-backed), adding 200+ MW. Google will backstop $1.8B of Fluidstack's lease obligations and receive an approximately 8% equity stake in TeraWulf. The deal could reach $8.7B with extensions.
AIRO Group: Drone Earnings Soar, Defense Market Thrives
Aerospace-and-defense start-up AIRO Group reported better-than-expected Q2 2025 financial results, with sales of $24.6M and adjusted EBITDA of $4.7M. Post-IPO, AIRO is expanding drone and training operations.